Johnston, M. R. (2020). Chemistry of Cannabis: An Interdisciplinary Course. Journal of Chemical Education, 97(12), 4311-4315.
Bernstein, N., Gorelick, J., & Koch, S. (2019). Interplay between chemistry and morphology in medical cannabis (Cannabis sativa L.). Industrial Crops and Products, 129, 185-194.
Lal, S., Shekher, A., Narula, A. S., Abrahamse, H., & Gupta, S. C. (2021). Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacological Research, 163, 105302.
Abdel-Kader, M. S., Radwan, M. M., Metwaly, A. M., Eissa, I. H., Hazekamp, A., & ElSohly, M. A. (2023). Chemistry and biological activities of cannflavins of the cannabis plant. Cannabis and Cannabinoid Research, 8(6), 974-985.
Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018). Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. BioMed research international, 2018.
ElSohly, M., & Gul, W. (2014). Constituents of Cannabis sativa. Handbook of cannabis, 3(1093), 187-188.
Citti, C., Russo, F., Sgrò, S., Gallo, A., Zanotto, A., Forni, F., ... & Cannazza, G. (2020). Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence. Analytical and Bioanalytical Chemistry, 412, 4009-4022.
Brenneisen, R. (2007). Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In Marijuana and the Cannabinoids (pp. 17-49). Totowa, NJ: Humana Press.
Borille, B. T., González, M., Steffens, L., Ortiz, R. S., & Limberger, R. P. (2017). Cannabis sativa: a systematic review of plant analysis. Drug Analytical Research, 1(1), 1-23.
Atapattu, S. N., & Johnson, K. R. (2020). Pesticide analysis in cannabis products. Journal of Chromatography A, 1612, 460656.
Dawson, D., Stjepanovic, D., Lorenzetti, V., Cheung, C., Hall, W., & Leung, J. (2024). The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis. Drug and Alcohol Dependence, 111263.
Shafiee, A., Rafiei, M. A., Jafarabady, K., Eskandari, A., Abhari, F. S., Sattari, M. A., ... & Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta‐analysis. Brain and Behavior, 14(1), e3340.
Froude, A. M., Fawcett, E. J., Coles, A., Drakes, D. H., Harris, N., & Fawcett, J. M. (2024). The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis. Journal of Psychiatric Research.
Marquette, A., Iraniparast, M., & Hammond, D. (2024). Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study. BMJ open, 14(1), e077908.
Schlag, A. K., O'Sullivan, S. E., Zafar, R. R., & Nutt, D. J. (2021). Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics. Neuropharmacology, 191, 108586.
Maurer, G. E., Mathews, N. M., Schleich, K. T., Slayman, T. G., & Marcussen, B. L. (2020). Understanding cannabis-based therapeutics in sports medicine. Sports Health, 12(6), 540-546.
Legare, C. A., Raup-Konsavage, W. M., & Vrana, K. E. (2022). Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology, 107(3-4), 131-149.
Bougea, A., Koros, C., Simitsi, A. M., Chrysovitsanou, C., Leonardos, A., & Stefanis, L. (2020). Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review. Complementary therapies in clinical practice, 39, 101154.
Pattnaik, F., Nanda, S., Mohanty, S., Dalai, A. K., Kumar, V., Ponnusamy, S. K., & Naik, S. (2022). Cannabis: Chemistry, extraction and therapeutic applications. Chemosphere, 289, 133012.
Charitos, I. A., Gagliano-Candela, R., Santacroce, L., & Bottalico, L. (2021). The Cannabis spread throughout the continents and its therapeutic use in history. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders), 21(3), 407-417.
Fernández-Ruiz, J., Galve-Roperh, I., Sagredo, O., & Guzmán, M. (2020). Possible therapeutic applications of cannabis in the neuropsychopharmacology field. European Neuropsychopharmacology, 36, 217-234.
Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2022). Medicinal cannabis and central nervous system disorders. Frontiers in Pharmacology, 13, 881810.
Pusiak, R. J., Cox, C., & Harris, C. S. (2021). Growing pains: An overview of cannabis quality control and quality assurance in Canada. International Journal of Drug Policy, 93, 103111.
Mead, A. (2019). Legal and regulatory issues governing cannabis and cannabis-derived products in the United States. Frontiers in plant science, 10, 433747.
Pruyn, S. A., Wang, Q., Wu, C. G., & Taylor, C. L. (2022). Quality standards in state programs permitting cannabis for medical uses. Cannabis and Cannabinoid Research, 7(6), 728-735.
MacCallum, C. A., Lo, L. A., Pistawka, C. A., & Boivin, M. (2023). A clinical framework for evaluating cannabis product quality and safety. Cannabis and Cannabinoid Research, 8(3), 567-574.
Belackova, V. (2020). “The Good, the Bad, and the Ugly Weed”: How Consumers in Four Different Policy Settings Define the Quality of Illicit Cannabis. Contemporary Drug Problems, 47(1), 43-62.
Degenhardt, L., Hall, W., & Lynskey, M. (2001). The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Social psychiatry and psychiatric epidemiology, 36, 219-227.
Schmid, K., Schönlebe, J., Drexler, H., & Mueck-Weymann, M. (2010). The effects of cannabis on heart rate variability and well-being in young men. Pharmacopsychiatry, 43(04), 147-150.
Meeprom, S., Sathatip, P., Leruksa, C., Manosuthi, N., & Fakfare, P. (2023). Cannabis-infused food: Uncovering effective conditions for achieving well-being perception and choice behavior among young adult consumers. Food Quality and Preference, 109, 104915.
Shanahan, L., Steinhoff, A., Bechtiger, L., Copeland, W. E., Ribeaud, D., Eisner, M., & Quednow, B. B. (2021). Frequent teenage cannabis use: Prevalence across adolescence and associations with young adult psychopathology and functional well-being in an urban cohort. Drug and alcohol dependence, 228, 109063.
Fedorova, E. V., Wong, C. F., Conn, B. M., Ataiants, J., Iverson, E., & Lankenau, S. E. (2022). COVID-19’s impact on Substance Use and well-being of younger adult Cannabis users in California: a mixed methods Inquiry. Journal of drug issues, 52(2), 207-224.
Allen, I., Fitzer, S. A., Hanson, S. N., & Henson, J. M. (2024). Thriving or Coping: The Connection Between Well-Being and Cannabis Motives in College Life.
van Orten-Luiten, A. C. B., De Roos, N. M., Majait, S., Witteman, B. J., & Witkamp, R. F. (2022). Effects of cannabidiol chewing gum on perceived pain and well-being of irritable bowel syndrome patients: a placebo-controlled crossover exploratory intervention study with symptom-driven dosing. Cannabis and cannabinoid research, 7(4), 436-444.
Saleska, J. L., Pauli, E. K., Rezvan, P., Cobb, O., Chen, J., Thorogood, P., ... & Laird, K. T. (2022). The safety and effectiveness of commercially available cannabidiol products for health and well-being: a randomized, multi-arm, open-label waitlist-controlled trial. Integrative Medicine Reports, 1(1), 215-226.